Stroke Journal

FEBRUARY 1, 2024

Introduction:The paucity of large-scale data exploring the effect of prior bariatric surgery on recurrent stroke outcomes in elderly obese stroke survivors led us to address the gap, with an emphasis on the risk of recurrent stroke and its trends.Methods:A retrospective study was conducted using National Inpatient Sample data from 2016-2019.

Obesity 40

Obesity Inpatient Strokes Stroke 40

Journal of the American Heart Association

JANUARY 19, 2024

Methods and ResultsData were collected from the 2016 to 2018 National Inpatient Sample. The primary outcome of interest was variability in CLTI treatment, as characterized by the median odds ratio. BackgroundLittle is known about treatment variability across US hospitals for patients with chronic limb‐threatening ischemia (CLTI).Methods

Inpatient 40

Inpatient Ischemia Hospital Outcomes 40

DAIC

APRIL 8, 2024

However, the TACT2 results did not reveal any difference in the composite primary outcome of death from any cause, heart attack, stroke, coronary revascularization or hospitalization for unstable angina among people who received weekly edetate disodium-based infusions compared with those who received a placebo. and Canada.

Heart Attack 105

Heart Attack Heart attacks Outcomes Diabetes 105

Stroke Journal

FEBRUARY 1, 2024

Our study aims to describe the trends and outcomes of patients with Subarachnoid Hemorrhage (SAH) using a Nationwide Inpatient Sample (NIS) database.Methods:We examined the 2016-2020 NIS database, focusing on patients aged 18 years and older with a primary SAH discharge diagnosis.

COVID-19 40

COVID-19 Hemorrhage Outcomes Inpatient 40

Cardiology Update

DECEMBER 11, 2023

This unique setting allowed investigators to examine the relationship between obesity and hemodynamic indices of right ventricular function, as well as how right ventricular function correlates with future clinical outcomes. Original article: Circ Heart Fail. 2023;16:e010524.

Obesity 52

Obesity Hospital Outcomes Heart Failure 52

Stroke Journal

FEBRUARY 1, 2024

Introduction:Previous studies have demonstrated the predictive capabilities of machine learning (ML) models using clinical, imaging, and angiographic characteristics in determining the clinical outcome of patients undergoing endovascular treatment for acute ischemic stroke. The area under the curve for predicting good outcome was 0.76

Strokes 40

Strokes Stroke Outcomes Laboratory 40

Open Heart

DECEMBER 9, 2023

Methods Adult patients with TAAD from China 5A study were included if surgically repaired between 2016 and 2022. Primary outcome was operative mortality according to Society of Thoracic Surgeons criterion.

Aortic 52

Aortic Outcomes 52

Stroke: Vascular and Interventional Neurology

SEPTEMBER 12, 2023

We investigated long‐term trends of reperfusion therapy and outcomes according to the stroke severity.MethodsPatients with acute ischemic stroke registered in the prospective nationwide hospital‐based registry between 2000 and 2020 were examined. Secular changes were assessed per 5‐year cohorts (2000–2005, 2006–2010, 2011–2015, 2016–2020).

Strokes 40

Strokes Stroke Outcomes Thrombolysis 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:Atrial fibrillation (AF) and cancer are both independently associated with worse outcomes in patients with acute ischemic stroke. Few studies have evaluated the impact of AF on outcomes of cancer-related stroke. The primary outcome was in-hospital mortality. The primary exposure was a diagnosis of AF.

Cancer 40

Cancer Atrial Fibrillation Strokes Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Background:Studies describing outcomes of subarachnoid hemorrhage (SAH) in children are sparse. Conclusion:Six of ten pediatric patients with SAH are discharged with excellent outcome with a 10% index hospitalization mortality. Stroke, Volume 55, Issue Suppl_1 , Page ATP19-ATP19, February 1, 2024.

Pediatrics 40

Pediatrics Hemorrhage Outcomes Inpatient 40

Stroke Journal

MARCH 21, 2024

BACKGROUND:Patient-reported outcome measures (PROMs) describe health status from the perspective of the patient. Using the trial’s primary publication and protocol, we abstracted key study characteristics including all primary and secondary outcome measures. Only 1 trial used a PROM as a primary outcome.

Strokes 40

Strokes Stroke Outcomes Quality of Life 40

Open Heart

APRIL 27, 2023

This study used data from Ontario, Canada to compare mid-term and long-term clinical outcomes in a representative real-world cohort of patients who underwent TAVR and SAVR from 2007 to 2016. Primary outcomes were all-cause, cardiovascular and non-cardiovascular mortality either in-hospital or at 1, 3 and 5 years postdischarge.

Aortic valve 52

Aortic valve TAVR Aortic Outcomes 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Whereas secondary analyses from randomized trials have demonstrated no differences in thrombectomy outcomes in transferred vs direct presentation strokes (1‐2), several registry based cohorts reported worse functional outcomes in those with transferred presentation mode (3‐4).

Hospital 40

Hospital Outcomes Strokes Stroke 40

Circulation: Heart Failure

OCTOBER 27, 2023

The role of obesity in RV dysfunction and adverse outcomes is unclear.METHODS:We examined patients undergoing right heart catheterization between 2005 and 2016 in a hospital-based cohort. BACKGROUND:Right ventricular (RV) dysfunction is associated with increased mortality across a spectrum of cardiovascular diseases.

Obesity 40

Obesity Outcomes Heart Failure Pulmonary 40

Circulation: Heart Failure

MARCH 8, 2024

Patient characteristics, outcomes, and procedural volume were compared among 3 cohorts: admissions to non-ATCs, admissions to ATCs, and transfers to ATCs. A secondary analysis evaluated outcomes for severe HF hospitalizations (cardiogenic shock, cardiac arrest, and mechanical ventilation).

Heart Failure 40

Heart Failure Cardiogenic Shock Outcomes Cardiac Arrest 40

Stroke Journal

FEBRUARY 1, 2024

We determined the utility of this score for predicting outcomes within one-year post-stroke/TIA.Methods:Analysis of adults with acute stroke/TIA (2012-2016) using linked data from the Australian Stroke Clinical Registry and administrative datasets (pharmaceutical, hospital, Medicare), as part of the PRECISE study.

Strokes 40

Strokes Stroke Outcomes Quality of Life 40

The American Journal of Cardiology

APRIL 19, 2024

Publication date: Available online 18 April 2024 Source: The American Journal of Cardiology Author(s): Bekure B. Siraw, Parth Patel, Abdulrahim Y. Mehadi, Eli A. Zaher, Yordanos T.

Inpatient 40

Inpatient Hospital Outcomes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

There is limited data on the influence of COVID‐19 on treatment and outcomes in patients with intracranial aneurysms. MethodsThis national, multicenter, retrospective cohort study included patients diagnosed and treated for IAs from January 2016 to December 2020 in the National Inpatient Sample (NIS). vs. 28.3%; p<0.001).

COVID-19 40

COVID-19 Aneurysm Outcomes Inpatient 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:Impact of race on outcomes in the treatment of intracranial aneurysm (IA) remains unclear. Data from 9 centers in the United States, Europe, and Asia for IA patients who undertook endovascular treatment (EVT) or microsurgical treatment (MST) between January 2016 and December 2020 were included for analysis. P< 001).

Aneurysm 40

Aneurysm Outcomes Strokes Stroke 40

Stroke Journal

FEBRUARY 1, 2024

We sought to determine association between intracranial atherosclerosis burden with vasospasm and outcomes in aSAH.Design/Methods:We performed a retrospective study of a prospectively collected cohort of consecutive patients with aSAH admitted to a Comprehensive Stroke Center between July 2016 and April 2023.

Atherosclerosis 40

Atherosclerosis Aneurysm Hemorrhage Outcomes 40

Journal of the American Heart Association

JANUARY 12, 2024

BackgroundReasons for racial disparities in the use and outcomes of endovascular treatment (ET) are not known. Using unadjusted and adjusted multilevel logistic models, we examined associations between measures of segregation and outcomes of discharge home, inpatient mortality, and 30‐day mortality.

Hospital 40

Hospital Outcomes Inpatient Strokes 40

Journal of the American Heart Association

JANUARY 19, 2024

Although Impella or intra‐aortic balloon pump (IABP) is frequently used for left ventricular unloading (LVU) during VA‐ECMO treatment, there are limited data on comparative outcomes. The proportion of patients receiving Impella significantly increased from 2016 to 2020 (6.5% and 16.4%, respectively. versus 25.8%;P‐trend<0.001).

Cardiogenic Shock 65

Cardiogenic Shock Aortic Hospital Outcomes 65

Circulation: Cardiovascular Quality & Outcomes

OCTOBER 19, 2023

Circulation: Cardiovascular Quality and Outcomes, Volume 16, Issue 11 , Page e010148, November 1, 2023. BACKGROUND:Although disparities in cardiac rehabilitation (CR) participation are well documented, the role of community-level distress is poorly understood.

Cardiac Rehabilitation 40

Cardiac Rehabilitation Inpatient Myocardial Infarction Outcomes 40

Cardiology Update

MARCH 17, 2024

Data were prospectively gathered from individuals aged 1 to under 18 years participating in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis long-term registry spanning from June 2014 to December 2016. Outcomes: Over a median follow-up of 12.5 months (IQR: 11.3–15.3),

Cardiomyopathy 119

Cardiomyopathy Pediatrics Heart Failure Research 119

Stroke Journal

FEBRUARY 1, 2024

In 2016, participants provided blood samples and methylation and genomic data was generated. Stage 1 entailed testing for association between BHe prior to 2016 (exposure) and epigenetic age (outcome). Stage 2 entailed testing for association between epigenetic age (exposure) and BHe occurring after 2016 (outcome).

Dementia 40

Dementia Strokes Stroke Outcomes 40

Open Heart

JANUARY 31, 2022

Objectives To understand the patient and hospital level drivers of the variation in surgical versus trascatheter aortic valve replacement (SAVR vs TAVR) for patients with aortic stenosis (AS) and to explore whether this variation translates into differences in clinical outcomes. Background Adoption of TAVR has grown exponentially worldwide.

Aortic valve 52

Aortic valve TAVR Aortic Outcomes 52

Stroke Journal

FEBRUARY 1, 2024

Annual follow-up interviews were conducted from inception until 2016 to determine outcomes of interest. A total of 181 outcomes occurred during the mean follow-up of 6.8 (6.8-6.9) Compared to females, males achieved higher scores in diet (44.9 P<0.001), physical activity (82.1 p<0.001), and body mass index (60.1

Myocardial Infarction 40

Myocardial Infarction Blood Pressure Outcomes Diet 40

Stroke Journal

FEBRUARY 1, 2024

Average procedure time increased over the years, with 30.1min in 2015, 34min in 2016, 44.9min in 2017, 52.3min in 2018, 45.9min in 2019, and 50.4min in 2020[F (5, 499)=7.7, Though procedure time increased over the years, this did not affect outcomes. Median ICU length of stay was 3[1-5] days. p<0.001]. 0.9], p=0.04).Conclusion:Overall,

Outcomes 40

Outcomes ICU Strokes Stroke 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionUnderstanding of patient benefit and improvement following mechanical thrombectomy in ischemic stroke has made tremendous strides in recent years, however clinicians still struggle to accurately predict patient outcomes and long‐term neurological functioning following large vessel occlusion and endovascular therapy.

Outcomes 40

Outcomes Strokes Stroke Hemorrhage 40

Coronary Artery Disease Journal

OCTOBER 31, 2023

Background It is unclear how COVID-19 pandemic affected care and outcomes among patients who are diagnosed with ST-elevation myocardial infarction (STEMI) in the USA. for patients admitted in 2016–2019 period. to 3.49, P < 0.001) were reduced in 2020 compared to 2016–2019 period. reduction in admissions in 2020. In 2020, 3.0%

COVID-19 52

COVID-19 STEMI Inpatient Hospital 52

Cardiovascular Diabetology

AUGUST 6, 2024

Cox proportional survival analysis was used to assess outcomes where cardioprotective GLD (any of Sodium Glucose Lowering Transport 2 receptor inhibitors [SGLT2i] and Glucagon Like Peptide Receptor Agonists [GLP-1 RA]) served as a reference. Mean age was 69 years, 67% were male, and 81% were on GLD. vs. 67.1%) than other GLD. vs. 5.2%).

Coronary Artery Disease 98

Coronary Artery Disease Diabetes Myocardial Infarction Heart Failure 98

Stroke Journal

FEBRUARY 1, 2024

We sought to assess predictors of ED mode of arrival and its effects on acute stroke care and inpatient outcomes in a large racial-ethnically diverse cohort.Methods:In 2016, we launched a system-wide standardized telestroke program for 21 certified stroke centers. 0.34; p=&lt;0.001).Conclusions:In

Strokes 40

Strokes Stroke Hospital Outcomes 40

Open Heart

MAY 8, 2024

Objective Implantable loop recorders (ILRs) are increasingly used for long-term rhythm monitoring after ischaemic and cryptogenic stroke, with the goal of detecting atrial fibrillation (AF) and subsequent initiation of oral anticoagulation to reduce risk of adverse clinical outcomes.

Strokes 73

Strokes Stroke Atrial Fibrillation Medicare 73

Stroke Journal

FEBRUARY 1, 2024

The hospitals were grouped into quartiles based on the volume of MT procedures performed within the calendar year.

Hospital 40

Hospital Strokes Stroke Outcomes 40

HeartRhythm

APRIL 30, 2024

Oral Anticoagulation, often necessary for the treatment of patients with AF presents a problem for patients at high risk for bleeding. This led to the development of LAAO devices which serve to occlude the left atrial appendage, a small portion of the left atrium where up to 91% of the AF-related thrombi form.

Ablation 40

Ablation Inpatient Atrial Fibrillation Hospital 40

Journal of the American Heart Association

DECEMBER 1, 2023

We investigated the efficacy and safety of treatment with each of 4 different DOACs or warfarin after DOAC failure.Methods and ResultsWe retrospectively analyzed patients with atrial fibrillation with ischemic stroke despite DOAC treatment between January 2002 and December 2016. 0.39] for apixaban, 0.23 [95% CI, 0.14–0.37]

Atrial Fibrillation 75

Atrial Fibrillation Hemorrhage Pharmacology Strokes 75

Heart BMJ

JUNE 25, 2024

The primary outcome was the first occurrence of major cardiovascular events defined as a composite of hospitalisation for acute coronary syndrome (non-fatal myocardial infarction and unstable angina), fatal myocardial infarction, non-fatal and fatal stroke, sudden death and heart failure. The overall median of follow-up duration was 4.6

Cardiovascular Disease 59

Cardiovascular Disease Myocardial Infarction Pharmacology Angina 59